We were primarily interested in evaluating changes in the levels of pathological tau species following a period of drug washout, as well as investigating secondary pathological mechanisms relevant to tissue homeostasis, such as glial function and brain inflammation, that are known players in several forms of dementia. The gene discussed is MAPT; the disease is dementia.